It may be hypothesized that the PI3K-Akt inhibitor LY294002 failed to protect mice from lung fibrosis and EMT in alveolar epithelial cells due to the differential effects of Akt isoforms, as well as the interaction of Akt on other proteins within the complex signaling network. This evidence concerns the gene AKT1 and pulmonary fibrosis.